Leon Moulder Oliver's most recent trade in Zenas Biopharma Inc. was a trade of 36,928 Common Stock done at an average price of $20.9 . Disclosure was reported to the exchange on Oct. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 20.85 per share. | 07 Oct 2025 | 36,928 | 36,928 | - | 20.9 | 769,949 | Common Stock |
| Zai Lab Ltd (ADR) | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 72,602 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Leon Moulder Oliver | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 18 Feb 2025 | 25,000 | 266,155 | - | 6.7 | 166,750 | Common Stock |